NovoMedix Patents – Insights & Stats

NovoMedix has a total of 54 patents globally, out of which 30 have been granted. Of these 54 patents, more than 74% patents are active. The United States of America is where NovoMedix has filed the maximum number of patents, followed by China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of NovoMedix.

NovoMedix was founded in 2001. NovoMedix has created brand-new, orally indigestible small compounds with broad therapeutic windows to treat fibroid diseases. While some of these compounds have special qualities for the treatment of cancer, others have demonstrated great success in animal models of fibrosis.

Do read about some of the most popular patents of NovoMedix which have been covered by us in this article and also you can find NovoMedix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over NovoMedix patent portfolio.

How many patents does NovoMedix have?

NovoMedix has a total of 54 patents globally. These patents belong to 5 unique patent families. Out of 54 patents, 40 patents are active.

How Many Patents did NovoMedix File Every Year?

NovoMedix Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantNovoMedix Applications FiledNovoMedix Patents Granted
20231
202172
20201
201912
2018110
201775
20161
201556
201412
201316
20124
201112

How many NovoMedix patents are Alive/Dead?

Worldwide Patents

NovoMedix Patent Portfolio

How Many Patents did NovoMedix File in Different Countries?

NovoMedix Worldwide Patent Filing

Countries in which NovoMedix Filed Patents

CountryPatent
United States Of America11
China5
Europe4
Canada4
Australia4
Mexico3
Germany2
Japan2
Singapore2
New Zealand2
Austria2
India2
Taiwan2
South Africa2
Denmark1
Spain1
Hong Kong (S.A.R.)1

Where are Research Centers of NovoMedix Patents Located?

The Research Centers of NovoMedix Patents is the United States of America.

What Percentage of NovoMedix US Patent Applications Were Granted?

NovoMedix (Excluding its subsidiaries) has filed 7 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 7 have been granted leading to a grant rate of 100%.

Below are the key stats of NovoMedix patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for NovoMedix?

Law FirmTotal ApplicationsSuccess Rate
Jones Day7100%

What are NovoMedix key innovation segments?

What Technologies are Covered by NovoMedix?

The chart below distributes patents filed by NovoMedix in different countries on the basis of the technology protected in patents. It also represents the markets where NovoMedix thinks it’s important to protect particular technology inventions.

R&D Focus: How has NovoMedix search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by NovoMedix?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.